Case Report
Published on 06 Feb 2026
Case Report: Targeting the Achilles’ heel of monomorphic epitheliotropic intestinal T-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1710764
- 443 views
Type at least 3 characters
2,053 articles
articles
Case Report
Accepted on 05 Feb 2026
Unmasking Small-Bowel DLBCL in an Elderly Patient with Simultaneous Multiple Primary Cancers through Anemia: A Case Report and Literature Review
in Hematologic Malignancies
Frontiers in Oncology
Review
Published on 05 Feb 2026
The role of epigenetic modifications in hematological cancers
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1744018
- 367 views
Original Research
Accepted on 04 Feb 2026
A Novel Prognostic Model Integrating Host Vulnerability and Tumor Biology for Elderly Patients with Diffuse Large B-Cell Lymphoma: The BAMAL Score
in Hematologic Malignancies
Frontiers in Oncology
Case Report
Accepted on 04 Feb 2026
Chidamide Combined with Decitabine, Venetoclax, and Low-Dose Cytarabine (LDAC) for Relapsed/Refractory Acute Myeloid Leukemia: A Single-Center Case Series
in Hematologic Malignancies
Frontiers in Oncology
Case Report
Accepted on 04 Feb 2026
Low-Grade B-Cell Non-Hodgkin Lymphoma in the Sternocleidomastoid Muscle: A Case Report and Review of Literature
in Hematologic Malignancies
Frontiers in Oncology
Brief Research Report
Accepted on 04 Feb 2026
TLK2 antisense oligonucleotide as a new strategy to target TLK2 in acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
Original Research
Published on 04 Feb 2026
Association between the prognostic nutritional index and early mortality of AML patients after allogeneic HSCT: a retrospective cohort analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1754463
- 286 views
Original Research
Published on 04 Feb 2026
Analysis of risk factors for PICC-related venous thrombosis in patients with hematological malignancies and establishment of a nomogram prediction model
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1675200
- 228 views
Original Research
Published on 03 Feb 2026
Metabolic Bulk Volume is an independent prognostic factor and facilitates identifying high risk cases for DLBCL patients treated with the R-CHOP
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1747186
- 303 views
Original Research
Accepted on 02 Feb 2026
Microtransplantation improves the outcome of older patients with newly diagnosed acute myeloid leukemia: a single-centre study with long-term follow-up
in Hematologic Malignancies
Frontiers in Oncology
Case Report
Accepted on 02 Feb 2026
Case Report and Literature Review: Golidocitinib as a Potential Treatment for Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma
in Hematologic Malignancies
Frontiers in Oncology
Case Report
Accepted on 02 Feb 2026
Case Report: Sorafenib-Induced Rhabdomyolysis in a Post-Transplant Patient with Acute Myeloid Leukemia
in Hematologic Malignancies
Frontiers in Oncology
Case Report
Published on 02 Feb 2026
Case Report: renal allograft infiltration by chronic lymphocytic leukemia successfully treated with zanubrutinib
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1765255
- 392 views
Case Report
Accepted on 30 Jan 2026
Case Report: Glofitamab in the Treatment of a Patient with Central Nervous System-Involved Burkitt Lymphoma
in Hematologic Malignancies
Frontiers in Oncology
- 549 views
Review
Accepted on 30 Jan 2026
OVERCOMING RESISTANCE TO IMMUNE CHECKPOINT INHIBITOR THERAPY IN ACUTE MYELOID LEUKEMIA
in Hematologic Malignancies
Frontiers in Oncology
- 370 views
Case Report
Accepted on 30 Jan 2026
Diagnosis and management of rare acute erythroid leukemia with hemophagocytic lymphohistiocytosis: a case report
in Hematologic Malignancies
Frontiers in Oncology
- 122 views
Original Research
Accepted on 30 Jan 2026
Advancing Access to Chimeric Antigen Receptor (CAR) T-cell Therapy in the Community: Insights and Real-World Experience From a Community Oncology Perspective
in Hematologic Malignancies
Frontiers in Oncology
- 137 views
Original Research
Published on 30 Jan 2026
Clinical characteristics, treatment patterns, and survival in mantle cell lymphoma: a real-world cohort
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1756632
- 536 views
Case Report
Published on 30 Jan 2026
Acquired immune deficiency syndrome-related intravascular large B-cell lymphoma primarily arising from lymph nodes: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1767472
- 400 views
Case Report
Published on 30 Jan 2026
Case Report: Urinary tract isolation of Cronobacter sakazakii in an oncohaematological patient in Southern Italy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1736054
- 445 views
Case Report
Published on 30 Jan 2026
Case Report: ALK-positive histiocytosis presenting as an adrenal mass: a diagnostic trap due to unusual morphology
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1765507
- 364 views
Original Research
Published on 30 Jan 2026
Identification of a neoplastic Tfh-like cellular subset in a mouse model of angioimmunoblastic T cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2026.1715613
- 744 views
Case Report
Accepted on 29 Jan 2026
Co-existence of BCR::PDGFRA gene fusion and PDGFRA variants in myeloid neoplasm with persistent leukocytosis, large splenomegaly, and eosinophilia
in Hematologic Malignancies
Frontiers in Oncology